Global and United States Human Somatotropin Market Report & Forecast 2024-2031

Report ID: 1845802 | Published Date: Jan 2025 | No. of Page: 102 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
1 Study Coverage
    1.1 Human Somatotropin Product Introduction
    1.2 Global Human Somatotropin Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Human Somatotropin Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Human Somatotropin Sales in Volume for the Year 2017-2028
    1.3 United States Human Somatotropin Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Human Somatotropin Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Human Somatotropin Sales in Volume for the Year 2017-2028
    1.4 Human Somatotropin Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Human Somatotropin in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Human Somatotropin Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Human Somatotropin Market Dynamics
        1.5.1 Human Somatotropin Industry Trends
        1.5.2 Human Somatotropin Market Drivers
        1.5.3 Human Somatotropin Market Challenges
        1.5.4 Human Somatotropin Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Human Somatotropin Market Segment by Type
        2.1.1 Powder
        2.1.2 Solvent
    2.2 Global Human Somatotropin Market Size by Type
        2.2.1 Global Human Somatotropin Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Human Somatotropin Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Human Somatotropin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Human Somatotropin Market Size by Type
        2.3.1 United States Human Somatotropin Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Human Somatotropin Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Human Somatotropin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Human Somatotropin Market Segment by Application
        3.1.1 Growth Hormone Deficiency (GHD)
        3.1.2 Turner Syndrome
        3.1.3 Chronic Renal Insufficiency
        3.1.4 Prader Willi Syndrome
        3.1.5 Small for Gestational Age
        3.1.6 SHOX Deficiency
        3.1.7 Others
    3.2 Global Human Somatotropin Market Size by Application
        3.2.1 Global Human Somatotropin Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Human Somatotropin Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Human Somatotropin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Human Somatotropin Market Size by Application
        3.3.1 United States Human Somatotropin Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Human Somatotropin Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Human Somatotropin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Human Somatotropin Competitor Landscape by Company
    4.1 Global Human Somatotropin Market Size by Company
        4.1.1 Top Global Human Somatotropin Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Human Somatotropin Revenue by Manufacturer (2017-2022)
        4.1.3 Global Human Somatotropin Sales by Manufacturer (2017-2022)
        4.1.4 Global Human Somatotropin Price by Manufacturer (2017-2022)
    4.2 Global Human Somatotropin Concentration Ratio (CR)
        4.2.1 Human Somatotropin Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Somatotropin in 2021
        4.2.3 Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Human Somatotropin Manufacturing Base Distribution, Product Type
        4.3.1 Global Human Somatotropin Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Human Somatotropin Product Type
        4.3.3 Date of International Manufacturers Enter into Human Somatotropin Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Human Somatotropin Market Size by Company
        4.5.1 Top Human Somatotropin Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Human Somatotropin Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Human Somatotropin Sales by Players (2020, 2021 & 2022)
5 Global Human Somatotropin Market Size by Region
    5.1 Global Human Somatotropin Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Human Somatotropin Market Size in Volume by Region (2017-2028)
        5.2.1 Global Human Somatotropin Sales in Volume by Region: 2017-2022
        5.2.2 Global Human Somatotropin Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Human Somatotropin Market Size in Value by Region (2017-2028)
        5.3.1 Global Human Somatotropin Sales in Value by Region: 2017-2022
        5.3.2 Global Human Somatotropin Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Human Somatotropin Market Size YoY Growth 2017-2028
        6.1.2 North America Human Somatotropin Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Human Somatotropin Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Human Somatotropin Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Indonesia
        6.2.9 Thailand
        6.2.10 Malaysia
        6.2.11 Philippines
        6.2.12 Vietnam
    6.3 Europe
        6.3.1 Europe Human Somatotropin Market Size YoY Growth 2017-2028
        6.3.2 Europe Human Somatotropin Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 UK
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Human Somatotropin Market Size YoY Growth 2017-2028
        6.4.2 Latin America Human Somatotropin Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Human Somatotropin Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Human Somatotropin Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Corporation Information
        7.1.2 Novo Nordisk Description and Business Overview
        7.1.3 Novo Nordisk Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Novo Nordisk Human Somatotropin Products Offered
        7.1.5 Novo Nordisk Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Corporation Information
        7.2.2 Pfizer Description and Business Overview
        7.2.3 Pfizer Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Pfizer Human Somatotropin Products Offered
        7.2.5 Pfizer Recent Development
    7.3 Eli Lilly
        7.3.1 Eli Lilly Corporation Information
        7.3.2 Eli Lilly Description and Business Overview
        7.3.3 Eli Lilly Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Eli Lilly Human Somatotropin Products Offered
        7.3.5 Eli Lilly Recent Development
    7.4 Merck Serono
        7.4.1 Merck Serono Corporation Information
        7.4.2 Merck Serono Description and Business Overview
        7.4.3 Merck Serono Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Merck Serono Human Somatotropin Products Offered
        7.4.5 Merck Serono Recent Development
    7.5 F. Hoffmann-La Roche
        7.5.1 F. Hoffmann-La Roche Corporation Information
        7.5.2 F. Hoffmann-La Roche Description and Business Overview
        7.5.3 F. Hoffmann-La Roche Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 F. Hoffmann-La Roche Human Somatotropin Products Offered
        7.5.5 F. Hoffmann-La Roche Recent Development
    7.6 Ferring Pharmaceuticals
        7.6.1 Ferring Pharmaceuticals Corporation Information
        7.6.2 Ferring Pharmaceuticals Description and Business Overview
        7.6.3 Ferring Pharmaceuticals Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Ferring Pharmaceuticals Human Somatotropin Products Offered
        7.6.5 Ferring Pharmaceuticals Recent Development
    7.7 GeneScience Pharmaceuticals
        7.7.1 GeneScience Pharmaceuticals Corporation Information
        7.7.2 GeneScience Pharmaceuticals Description and Business Overview
        7.7.3 GeneScience Pharmaceuticals Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 GeneScience Pharmaceuticals Human Somatotropin Products Offered
        7.7.5 GeneScience Pharmaceuticals Recent Development
    7.8 Ipsen
        7.8.1 Ipsen Corporation Information
        7.8.2 Ipsen Description and Business Overview
        7.8.3 Ipsen Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Ipsen Human Somatotropin Products Offered
        7.8.5 Ipsen Recent Development
    7.9 LG Life Sciences
        7.9.1 LG Life Sciences Corporation Information
        7.9.2 LG Life Sciences Description and Business Overview
        7.9.3 LG Life Sciences Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 LG Life Sciences Human Somatotropin Products Offered
        7.9.5 LG Life Sciences Recent Development
    7.10 Sandoz International
        7.10.1 Sandoz International Corporation Information
        7.10.2 Sandoz International Description and Business Overview
        7.10.3 Sandoz International Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Sandoz International Human Somatotropin Products Offered
        7.10.5 Sandoz International Recent Development
    7.11 Anhui Anke Biotechnology
        7.11.1 Anhui Anke Biotechnology Corporation Information
        7.11.2 Anhui Anke Biotechnology Description and Business Overview
        7.11.3 Anhui Anke Biotechnology Human Somatotropin Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Anhui Anke Biotechnology Human Somatotropin Products Offered
        7.11.5 Anhui Anke Biotechnology Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Human Somatotropin Industry Chain Analysis
    8.2 Human Somatotropin Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Human Somatotropin Distributors
    8.3 Human Somatotropin Production Mode & Process
    8.4 Human Somatotropin Sales and Marketing
        8.4.1 Human Somatotropin Sales Channels
        8.4.2 Human Somatotropin Distributors
    8.5 Human Somatotropin Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. Human Somatotropin CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Human Somatotropin Market Trends
    Table 3. Human Somatotropin Market Drivers
    Table 4. Human Somatotropin Market Challenges
    Table 5. Human Somatotropin Market Restraints
    Table 6. Global Human Somatotropin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Human Somatotropin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Human Somatotropin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Human Somatotropin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Human Somatotropin Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Human Somatotropin Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Human Somatotropin Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Human Somatotropin Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Human Somatotropin Sales Share by Manufacturer, 2017-2022
    Table 15. Global Human Somatotropin Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Human Somatotropin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Human Somatotropin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Somatotropin as of 2021)
    Table 18. Top Players of Human Somatotropin in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Human Somatotropin Product Type
    Table 20. Date of International Manufacturers Enter into Human Somatotropin Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Human Somatotropin Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Human Somatotropin Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Human Somatotropin Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Human Somatotropin Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Human Somatotropin Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Human Somatotropin Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Human Somatotropin Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Human Somatotropin Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Human Somatotropin Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Human Somatotropin Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Human Somatotropin Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Human Somatotropin Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Human Somatotropin Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Human Somatotropin Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Human Somatotropin Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Human Somatotropin Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Human Somatotropin Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Human Somatotropin Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Human Somatotropin Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Human Somatotropin Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Novo Nordisk Corporation Information
    Table 43. Novo Nordisk Description and Business Overview
    Table 44. Novo Nordisk Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Novo Nordisk Human Somatotropin Product
    Table 46. Novo Nordisk Recent Development
    Table 47. Pfizer Corporation Information
    Table 48. Pfizer Description and Business Overview
    Table 49. Pfizer Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Pfizer Product
    Table 51. Pfizer Recent Development
    Table 52. Eli Lilly Corporation Information
    Table 53. Eli Lilly Description and Business Overview
    Table 54. Eli Lilly Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Eli Lilly Product
    Table 56. Eli Lilly Recent Development
    Table 57. Merck Serono Corporation Information
    Table 58. Merck Serono Description and Business Overview
    Table 59. Merck Serono Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Merck Serono Product
    Table 61. Merck Serono Recent Development
    Table 62. F. Hoffmann-La Roche Corporation Information
    Table 63. F. Hoffmann-La Roche Description and Business Overview
    Table 64. F. Hoffmann-La Roche Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. F. Hoffmann-La Roche Product
    Table 66. F. Hoffmann-La Roche Recent Development
    Table 67. Ferring Pharmaceuticals Corporation Information
    Table 68. Ferring Pharmaceuticals Description and Business Overview
    Table 69. Ferring Pharmaceuticals Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Ferring Pharmaceuticals Product
    Table 71. Ferring Pharmaceuticals Recent Development
    Table 72. GeneScience Pharmaceuticals Corporation Information
    Table 73. GeneScience Pharmaceuticals Description and Business Overview
    Table 74. GeneScience Pharmaceuticals Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. GeneScience Pharmaceuticals Product
    Table 76. GeneScience Pharmaceuticals Recent Development
    Table 77. Ipsen Corporation Information
    Table 78. Ipsen Description and Business Overview
    Table 79. Ipsen Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Ipsen Product
    Table 81. Ipsen Recent Development
    Table 82. LG Life Sciences Corporation Information
    Table 83. LG Life Sciences Description and Business Overview
    Table 84. LG Life Sciences Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. LG Life Sciences Product
    Table 86. LG Life Sciences Recent Development
    Table 87. Sandoz International Corporation Information
    Table 88. Sandoz International Description and Business Overview
    Table 89. Sandoz International Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Sandoz International Product
    Table 91. Sandoz International Recent Development
    Table 92. Anhui Anke Biotechnology Corporation Information
    Table 93. Anhui Anke Biotechnology Description and Business Overview
    Table 94. Anhui Anke Biotechnology Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. Anhui Anke Biotechnology Product
    Table 96. Anhui Anke Biotechnology Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Human Somatotropin Customers List
    Table 100. Human Somatotropin Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Somatotropin Product Picture
    Figure 2. Global Human Somatotropin Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Human Somatotropin Market Size 2017-2028 (US$ Million)
    Figure 4. Global Human Somatotropin Sales 2017-2028 (MT)
    Figure 5. United States Human Somatotropin Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Human Somatotropin Market Size 2017-2028 (US$ Million)
    Figure 7. United States Human Somatotropin Sales 2017-2028 (MT)
    Figure 8. United States Human Somatotropin Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Human Somatotropin Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Human Somatotropin Report Years Considered
    Figure 11. Product Picture of Powder
    Figure 12. Product Picture of Solvent
    Figure 13. Global Human Somatotropin Market Share by Type in 2022 & 2028
    Figure 14. Global Human Somatotropin Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Human Somatotropin Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Human Somatotropin Sales by Type (2017-2028) & (MT)
    Figure 17. Global Human Somatotropin Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Human Somatotropin Price by Type (2017-2028) & (USD/MT)
    Figure 19. United States Human Somatotropin Market Share by Type in 2022 & 2028
    Figure 20. United States Human Somatotropin Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Human Somatotropin Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Human Somatotropin Sales by Type (2017-2028) & (MT)
    Figure 23. United States Human Somatotropin Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Human Somatotropin Price by Type (2017-2028) & (USD/MT)
    Figure 25. Product Picture of Growth Hormone Deficiency (GHD)
    Figure 26. Product Picture of Turner Syndrome
    Figure 27. Product Picture of Chronic Renal Insufficiency
    Figure 28. Product Picture of Prader Willi Syndrome
    Figure 29. Product Picture of Small for Gestational Age
    Figure 30. Product Picture of SHOX Deficiency
    Figure 31. Product Picture of Others
    Figure 32. Global Human Somatotropin Market Share by Application in 2022 & 2028
    Figure 33. Global Human Somatotropin Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 34. Global Human Somatotropin Sales Market Share in Value by Application (2017-2028)
    Figure 35. Global Human Somatotropin Sales by Application (2017-2028) & (MT)
    Figure 36. Global Human Somatotropin Sales Market Share in Volume by Application (2017-2028)
    Figure 37. Global Human Somatotropin Price by Application (2017-2028) & (USD/MT)
    Figure 38. United States Human Somatotropin Market Share by Application in 2022 & 2028
    Figure 39. United States Human Somatotropin Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 40. United States Human Somatotropin Sales Market Share in Value by Application (2017-2028)
    Figure 41. United States Human Somatotropin Sales by Application (2017-2028) & (MT)
    Figure 42. United States Human Somatotropin Sales Market Share in Volume by Application (2017-2028)
    Figure 43. United States Human Somatotropin Price by Application (2017-2028) & (USD/MT)
    Figure 44. North America Human Somatotropin Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 45. North America Human Somatotropin Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. United States Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Canada Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Mexico Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Human Somatotropin Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 50. Europe Human Somatotropin Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. UK Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Human Somatotropin Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 57. Asia-Pacific Human Somatotropin Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Indonesia Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Thailand Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Malaysia Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Philippines Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Vietnam Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Human Somatotropin Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 69. Latin America Human Somatotropin Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Human Somatotropin Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 74. Middle East & Africa Human Somatotropin Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. UAE Human Somatotropin Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Human Somatotropin Value Chain
    Figure 79. Human Somatotropin Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Frequently Asked Questions
Human Somatotropin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Somatotropin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Somatotropin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports